Telisotuzumab vedotin | c-Met inhibitor | Read Reviews & Product Use Citations

Telisotuzumab vedotin (Teliso-V, ABBV-399) is an antibody-drug conjugate (ADC) composed of the anti–c-Met humanized monoclonal antibody coupled to the cytotoxic monomethyl auristatin E (MMAE) through a mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used for research on advanced solid tumours.

CAS No. 1714088-51-3

Click to purchase products related to Telisotuzumab vedotin

Purity & Quality Control

Batch: D404601 Purity: 99.1% Protein concentration: 3.28mg/ml Endotoxin Level: ＜1EU/mg

99.1

Choose Selective c-Met Inhibitors

Biological Activity

Description	Telisotuzumab vedotin (Teliso-V, ABBV-399) is an antibody-drug conjugate (ADC) composed of the anti–c-Met humanized monoclonal antibody coupled to the cytotoxic monomethyl auristatin E (MMAE) through a mc-val-cit-PABC type linker. Telisotuzumab vedotin can be used for research on advanced solid tumours.

References
[1] Strickler JH, et al. J Clin Oncol. 2018 Nov 20;36(33):3298-3306.

References

[1] Strickler JH, et al. J Clin Oncol. 2018 Nov 20;36(33):3298-3306.

Product Details

CAS No.	1714088-51-3
DAR	3.71
ADC antiody	Telisotuzumab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field